Vifor Pharma AG (VIFN)
Vifor Pharma AG engages in the manufacturing, development and sale of pharmaceutical products for the treatment of iron deficiency. The company also offers a diversified portfolio of prescription medicines as well as over-the-counter products. It operates through the following segments: Vifor Pharma, Health & Beauty, and Services. The Vifor Pharma segment operates a fully integrated, international speciality pharmaceutical company that researches, develops and produces its own pharmaceutical products, and markets and distributes them worldwide. The Health & Beauty segment comprises two business sectors: Products & Brands and Retail. The Products & Brands sector is made up of Vifor Consumer Health and G-Pharma. The G-Pharma sector is a service provider for own brands and commercial products, launches and distributes pharmaceutical and para-pharmaceutical products and offers marketing and sales services. The Services segment offers pharmaceutical and healthcare companies pre-wholesale services, from storage and distribution of products in Switzerland to debt collection. The company's brands include Ferinject, Venofer and Maltofer. Vifor Pharma was founded in 1927 and is headquartered in Bern, Switzerland.
|Market Price at 17-01-2018||SFr. 136.60|
|Price to Earnings Ratio||28.94|
|Market Capitalisation||SFr. 8'898.50 (million)|
|Return on Equity (ROE)||12.12%|